YEAR
- 2013.12.30 Primary tumours modulate innate immune signalling to create pre-metastatic vascular hyperpermeability foci. Hiratsuka S, Ishibashi S, Tomita T, Watanabe A, Akashi-Takamura S, Murakami M, Kijima H, Miyake K, Aburatani H, Maru Y.Nat Commun. 2013;4:1853. doi: 10.1038/ncomms2856
- 2013.12.22 Pathogenic conversion of Foxp3+ T cells into TH17 cells in autoimmune arthritis. Komatsu N, Okamoto K, Sawa S, Nakashima T, Oh-hora M, Kodama T, Tanaka S, Bluestone JA, Takayanagi H.Nat. Med. 2014 Jan;20(1):62-8. doi: 10.1038/nm.3432
- 2013.12.18 In vitro selection of the 3'-untranslated regions of the human liver mRNA that bind to the HCV nonstructural protein 5B. Yuhashi K, Ohnishi S, Kodama T, Koike K, Kanamori H.Virology. 2014 Feb;450-451:13-23. doi: 10.1016/j.virol.2013.11.036
- 2013.12.17 Angiotensin receptor 1 blocker valsartan normalizes gene expression profiles of 3T3-L1 adipocytes altered by co-culture with LPS-treated RAW264.7 macrophages. Kumamoto S, Kushiyama A, Nakatsu Y, Sakoda H, Fujishiro M, Iwashita M, Ohno H, Zhang J, Guo Y, Aburatani H, Kamata H, Nishimura F, Asano T.Obes Res Clin Pract. 6(4):e263-346. doi: 10.1016/j.orcp.2012.05.005
- 2013.12.12 Mutational analysis reveals the origin and therapy-driven evolution of recurrent glioma. Johnson BE, Mazor T, Hong C, Barnes M, Aihara K, McLean CY, Fouse SD, Yamamoto S, Ueda H, Tatsuno K, Asthana S, Jalbert LE, Nelson SJ, Bollen AW, Gustafson WC, Charron E, Weiss WA, Smirnov IV, Song JS, Olshen AB, Cha S, Zhao Y, Moore RA, Mungall AJ, Jones SJM, Hirst M, Marra MA, Saito N, Aburatani H, Mukasa A, Berger MS, Chang SM, Taylor BS, Costello JF.Science. 2014 Jan 10;343(6167):189-193. doi: 10.1126/science.1239947
- 2013.12.09 A mesodermal factor, T, specifies mouse germ cell fate by directly activating germline determinants. Aramaki S, Hayashi K, Kurimoto K, Ohta H, Yabuta Y, Iwanari H, Mochizuki Y, Hamakubo T, Kato Y, Shirahige K, Saitou M.Dev. Cell. 2013 Dec 09;27(5):516-29. doi: 10.1016/j.devcel.2013.11.001
- 2013.12.05 Aberrantly methylated genes in human papillary thyroid cancer and their association with BRAF/RAS mutation. Kikuchi Y, Tsuji E, Yagi K, Matsusaka K, Tsuji S, Kurebayashi J, Ogawa T, Aburatani H, Kaneda A.Front Genet. 2013;4:271. doi: 10.3389/fgene.2013.00271
- 2013.12.05 The HSP90 inhibitor 17-N-allylamino-17-demethoxy geldanamycin (17-AAG) synergizes with cisplatin and induces apoptosis in cisplatin-resistant esophageal squamous cell carcinoma cell lines via the Akt/XIAP pathway. Ui T, Morishima K, Saito S, Sakuma Y, Fujii H, Hosoya Y, Ishikawa S, Aburatani H, Fukayama M, Niki T, Yasuda Y.Oncol. Rep. 2014 Feb;31(2):619-24. doi: 10.3892/or.2013.2899
CLOSE